Amebiasis is a disease of global importance caused by the protozoan *Entamoeba histolytica*. It is estimated that between 40,000 and 110,000 people die from this disease annually \[[@B1]\]. The protozoan has 2 stages: the cyst, which is its infectious form, and the trophozoite, which is the invasive form. Transmission is achieved by the consumption of water and food contaminated with mature cysts. This protozoan can live as commensals in the large intestine or invade the intestinal mucosa, causing ulcerations and extraintestinal locations, predominantly in the liver \[[@B2]\]. There are characteristic molecules involved in the virulence of the parasite, such as cysteine proteases, pore-forming proteins and lectins, which allow various activities, such as phagocytosis and tissue invasion \[[@B3],[@B4]\]. It has been demonstrated that the inhibition of gene expression using antisense sequences blocks the production of molecules that can decrease virulence-altering cytopathic or cytotoxic events or phagocytosis \[[@B5],[@B6],[@B7],[@B8]\]. However, blocking these cellular factors does not completely inhibit the pathogenicity of the protozoan.

It has been reported that transcriptomes from cell lines derived from the HM-1:IMSS strain have lost the ability to cause amebic liver abscesses (ALA) compared with virulent cell lines of the same strain, and several genes were identified, including ribosomal proteins, grainin-1, flavoproteins, GTP binding proteins, and GTPase, which confer resistance to bacterial infections, Ariel-1, and genes that encode proteins rich in lysine and glutamic acid \[[@B9]\]. In addition, it has been shown that trophozoites of the *E. histolytica* strain HM-1: IMSS can be cultured in TYI-S-33 medium for 1 or more years and demonstrate different levels of virulence with respect to trophozoites that have passed through the hamster liver due to the rapid response of the host\'s defense mechanisms \[[@B10]\]. To determine which molecules enable the differentiation between strains that cause damage from strains that do not cause damage, we used in vivo models, such as the hamster, that develops ALA with similar characteristics to human abscesses \[[@B11]\]. In addition, the molecules that are expressed in this process represent probable pathogenicity markers. Interestingly, the *mak16* gene was obtained by hybridization subtraction of an invasive amoeba from another amoeba that is not. In addition, it has been reported that this gene is involved in metabolic processes, such as the transport of molecules to the nucleolus and in ribosome biosynthesis. It has also been described that *mak16 mutants* sensitive to temperature do not allow G1 phase cell cycle arrest to occur.

Trophozoites of *E. histolytica* HM-1:IMSS were axenically cultured in TYI-S-33 medium (TAXE) \[[@B12]\] and divided into 2 groups. One group consisted of 10^6^ trophozoites that were intrahepatically inoculated into 2 male hamsters (*Mesocricetus auratus*), 6-week-old, with an average weight of 50 g \[[@B13]\]. Eight days post-inoculation, laparotomy was performed, and the trophozoites were isolated and cultured in TYI-S-33 media (TALA).

The RNA from a suspension of 10^3^ *E. histolytica* TAXE trophozoites and an equal number of TALA trophozoites was extracted using an RNAqueous kit (Ambion, Austin, Texas, USA), and subtractive hybridization was performed using the PCR-Select™ cDNA subtraction kit (Clontech, Palo Alto, California, USA). The cDNAs (100 ng) from the amoebas that had passed through the hamster liver and did not hybridize with the culture amebas were cloned into the pCR® 2.1 TOPO vector (Invitrogen, Carlsbad, California, USA) and then transformed into *E. coli* TOP10 competent bacteria. Subsequently, the plasmid DNA was isolated with a Miniprep kit (Roche, Penzberg, Germany).

For the sequencing reaction, we used 200 ng of plasmid DNA, 10× enzyme buffer, 8 U of *Taq* polymerase, 15 mM MgCl~2~, and 200 µM nucleotides. The sequencing was performed as follows: 1 cycle of denaturation for 5 min, 25 cycles of 96℃ for 10 sec, 50℃ for 5 min, and 60℃ for 4 min and 1 cycle of 60℃ for 7 min. The ABIPRISM model 310, v.3.4 ABI-CE 1 v.3.2 software was used for sequencing. The obtained DNA sequences were compared to the TIGR *E. histolytica* genome and to sequences in the GenBank, KEGG *E. histolytica* and Pathema-Entamoeba databases \[[@B14]\].

*E. histolytica* cysts were collected from the feces of 29 patients (aged 15-20 years). Ten of the patients had intestinal symptoms (constipation alternating with diarrhea or semiformed stools, abdominal cramps), and 19 patients were asymptomatic. The Faust method \[[@B15]\] was used, and the cysts were cultured in Robinson medium \[[@B16]\]. To identify *E. histolytica* isolates, amplification was performed for the 530-bp *enhhic* gene, which encodes the 30-kDa cysteine protease (data not shown) \[[@B17]\].

Subsequently, each isolate (10^5^ trophozoites) was inoculated intrahepatically in groups of 2 male hamsters (*M. auratus*). Eight days later, the liver was removed, and the trophozoites of *E. histolytica* were recovered in Robinson medium. Next, 10^4^ trophozoites were harvested, and their DNA was extracted using the Wizard genomic kit (Promega, Madison, Wisconsin, USA). Oligonucleotides were designed to amplify the *mak16* gene using the PRIMER3 program (<http://www-genome.wi.mit.edu/cgi-bin/primer/primer3_www.cgi>): F, 5\'-CGAATGGCCAAACTTGATTT-3\'; R, 5\'-CAAACGTT CTGCCCAATCTT-3\'. Amplification was performed using PCR in a 25-µl reaction mixture containing the following components: 800 ng of amoeba DNA cultured in Robinson medium, 1× enzyme buffer, 1.5 mM MgCl~2~, 200 µM of each dNTPs, 0.05 µM primers and 1.5 U of *Taq* polymerase. The amplification program consisted of 1 cycle of 94℃ for 5 min, 30 cycles of 94℃ for 1 min and 30 sec, 55℃ for 1 min and 72℃ for 2 min, and 1 extension cycle of 72℃ for 15 min. Subsequently, the amplified product was separated on a 1.5% agarose gel, stained with ethidium bromide and visualized using a UV light transilluminator. The amplicons were sequenced according to the described procedure and compared with the *mak16* sequence reported in GenBank. The use of *E. histolytica* cultures as well as the management of cysts obtained from the feces samples of patients was approved by the Ethics Committee of the Hospital Infantil de México Federico Gómez (HIMFG). All of the clinical investigations were performed according to the principles expressed in the Helsinki Declaration. Animals used in this experiment as well as the procedures for their sacrifice were performed according to the technical specifications delineated in the Mexican Official Standard (NOM-062-ZOO-1999) for the production, care and use of laboratory animals.

We performed Fisher\'s exact test with PASW statistics 18 to determine the association between the development of ALA in hamsters and the amplification of the *mak16* gene and between the presence of intestinal symptoms and the amplification of the *mak16* gene.

[Fig. 1A](#F1){ref-type="fig"} shows the cDNA of trophozoites of *E. histolytica* TALA obtained before subtractive hybridization with trophozoites of *E. histolytica* TAXE, and an intense band with a molecular size between 500 and 1,000 bp was observed. [Fig. 1B](#F1){ref-type="fig"} shows the decrease in the concentration of cDNA from trophozoites of *E. histolytica* TALA after subtractive hybridization.

[Table 1](#T1){ref-type="table"} shows that the sequences analyzed, which corresponded to 6 sequences obtained by subtractive hybridization, demonstrated a similarity with proteins reported in the database of the Genomic Research Institute for *E. histolytica*. These proteins were ribosomal protein L30 of the 60S subunit (XP_649197.1, 360 bp), nitrile hydratase alpha chain (CAC83631.1, 79 bp), MAK16 (XP_655185.1, 360 bp), cyclophilin (AF017993.1, 520 bp), hemolysins (HLY1, 5mc1, 5mcz y4, 475 bp), episomal rRNA (Z29969.1, 475 bp), and 40s ribosomal protein S3a (XM_647307.2, 257 bp).

Five of the 10 isolates of *E. histolytica* obtained from samples of the feces of symptomatic patients developed amebic abscesses in the hamsters\' livers and reached 50% of the tissue, including the parenchyma and the internal region of the organ. In addition, these isolates amplified a 216-bp fragment corresponding to the *mak16* gene ([Fig. 2](#F2){ref-type="fig"}). Nineteen isolates from asymptomatic patients did not amplify the *mak16* gene and did not result in the development of ALA in hamsters. The protein sequence of *mak16* presented alignment with the reported sequence pfam04874 with an E value of 3.35e^-06^. [Table 2](#T2){ref-type="table"} shows the comparison of a specific protein region of *mak16* of *E. histolytica* vs the protein sequences reported for *mak16* in 3 parasites (the flatworm parasite *Schistosoma mansoni* and the protozoans *Cryptosporidium muris* and *Toxoplasma gondii*), and the percentages obtained were less than 50%. With respect to the amplifications obtained from the isolates from patients who developed ALA, 3 of the 4 isolates of *E. histolytica* exhibited an identity of \>93%, whereas the other isolate presented an identity of 56%. The confidence index analyzed using the Fisher\'s exact test was *P*\<0.001 between ALA and the amplification of the *mak16* gene and *P*=0.002 between the appearance of symptoms in patients and the amplification of the gene.

We identified the *mak16* gene when it was expressed in trophozoites from the axenic strain of *E. histolytica* HM-1:IMSS, the virulence of which was stimulated by passage through the hamster liver. These virulent trophozoites were subjected to subtractive hybridization with trophozoites of the same strain that were not passaged through the hamster liver. However, this strain demonstrated attenuated virulence with longer culture time. These procedures occurred because the trophozoites in culture frequently changed their phenotypes and lost their virulence in axenic cultures, which was recovered by passage through the hamster liver \[[@B18]\]. The hepatic abscess that developed with isolates obtained from patients\' feces samples presented variability in size, i.e., from punctiform lesions to masses that encompassed 50% of the organ. This finding suggests that *E. histolytica* exhibits different levels of pathogenicity. Thus, we may infer that the ability to cause biological damage is associated with different factors of the parasite \[[@B19]\].

Alignment of the amino acid sequences of the *mak16* obtained from the patients\' samples showed identity greater than 93% with respect to *E. histolytica* HM-1:IMSS. Thus, we can infer that the trophozoites of *E. histolytica* present genetic diversity in the *mak16* that could be correlated with different pathogenicity levels. The development of ALA as well as the host-parasite interaction has been reported; nevertheless, the *mak16* gene has not been studied in *E. histolytica*.

The *mak16* gene demonstrated its origin when were studied some strains of *Saccharomyces cerevisia*e (K1 killers), which secretes a protein toxin that kills other sensitive strains. The genes encoding toxin production and resistance are localized on a 1.5-megadalton linear double-stranded (ds) RNA molecule known as M1. There are at least 28 nuclear genes that are required for the replication or maintenance of M dsRNA or killer plasmid. To further study and control the interactions of *mak* genes and the killer plasmid, were isolated a series of temperature-sensitive (Ts) mak mutants. The *mak16* is defined by the thermosensitive lethal *mak16-1* mutation, which results in the loss of M1 double-stranded RNA virus-like particles and is an essential gene localized on chromosome no. I. The *mak16* gene was sequenced, and an open reading frame of 306 amino acids encoding a predicted protein of 35 kDa was found. In the C-terminal third of the *MAK16* open reading frame is an acidic region in which 25 of 41 residues are either glutamate or aspartate. This region contains potential phosphorylation sites that are specific for serine or threonine residues. In addition, MAK16 proteins display a similar degree of sequence homology to the predicted protein CeMAK16 in *Caenorhabditis elegans*, the *SmMAK16* gene in *S. mansoni* and the putative *MAK16* protein in *E. histolytica* HM-1: IMSS.

A high degree of sequence conservation combined with the ability to direct nucleolar protein transport supports the hypothesis that *MAK16* proteins play a key role in the biogenesis of 60S ribosomal subunits \[[@B20],[@B21]\]. Ribosomal synthesis is a process that consumes a large amount of cell resources and is thus tightly regulated \[[@B22]\]. A change in the secretory pathway caused by stress may be due to the environment, i.e., the environment in which *E. histolytica* is grown affects its expression of the *mak16* gene and thus influences the gene transcription of ribosomal proteins and rRNA. However, if MAK proteins intervene in the phosphorylation of kinase protein molecules important for intra- and intercellular communication, they may also affect the signal transduction process, reorganization of the cytoskeleton, and migration \[[@B23]\]. Importantly, kinase proteins have recently been considered attractive targets for treatments against cancer and inflammatory processes \[[@B24]\], which are events that have been associated with the mechanisms of invasiveness of *E. histolytica* \[[@B25]\]. Thus, identification of the *mak16* gene in relationship to the development of ALA indicates that it is an important gene in these processes.
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![cDNAs obtained from the hybridization of *E. histolytica* HM-1:IMSS TAXE (trophozoites from culture) and TALA (trophozoites from amebic liver abscess). The electrophoretic separation was performed using a 1.5% agarose gel. (A) Lane 1, cDNAs of trophozoites of *E. histolytica* TALA; Lane m, molecular weight marker pBR322 cut with AvaII/EcoR1 (BioRad). (B) Lane 1, cDNAs obtained after subtractive hybridization between trophozoites of *E. histolytica* TAXE and TALA. Lane m, molecular weight marker pBR322 cut with AvaII/EcoR1 (BioRad).](kjp-52-429-g001){#F1}

![Amplification of *mak16* of *E. histolytica*. Electrophoresis was performed using a 1.5% agarose gel. The amplification of *mak16* was obtained from trophozoites without encystation that were obtained from patients with symptoms of amebiasis. The products were 216 bp in length. Lane m, molecular weight marker of 0.5-4.0 kb (BioRad). Five of the 10 isolates of *E. histolytica* that resulted in the development of liver abscesses amplified a 216-bp fragment corresponding to the *mak16* gene; lanes 1-5, samples 1-5. Lane 6 is the reactive control.](kjp-52-429-g002){#F2}
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